InspiroGene’s 2025 Cell and Gene Therapy Report reveals that while innovation and clinical experience with CGTs are accelerating, persistent access, reimbursement, and evidence challenges continue to slow their path to widespread adoption.
InspiroGene’s 2025 Cell and Gene Therapy Report reveals that while innovation and clinical experience with CGTs are accelerating, persistent access, reimbursement, and evidence challenges continue to slow their path to widespread adoption.
InspiroGene’s 2025 Cell and Gene...